# US Specialty Formulations LLC - Inspection Records

Source: https://www.keypedia.com/companies/us-specialty-formulations-llc/2a5dd57a-6a0b-44a4-88ec-d642f91d1315

> Inspection records and compliance data for US Specialty Formulations LLC in Allentown, Pennsylvania. Access full analysis and detailed observations.

---

## Details

- Name: US Specialty Formulations LLC
- FEI Number: 3010680515
- City: Allentown
- State: Pennsylvania
- Country Name: United States
- Address Line 1: 1401 S Albert St
- Zip Code: 18103

## Related Documents

- [483 - US Specialty Formulations LLC - Unknown Date](https://www.keypedia.com/records/483/us-specialty-formulations-llc/4dd416c3-7118-437a-bcb5-8ca83ae76b15) — source: FDA, date: Invalid Date
- [FDA Inspection 1298396 - US Specialty Formulations LLC - 2026-01-14](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/e72c419c-3eb9-4794-a8df-38ab824d37c6) — source: FDA, date: January 14, 2026
- [483 - US Specialty Formulations LLC - 2025-03-26](https://www.keypedia.com/records/483/us-specialty-formulations-llc/a05165b7-ed9d-4680-b279-3e464026ec25) — source: FDA, date: March 26, 2025
- [FDA Inspection 1265449 - US Specialty Formulations LLC - 2025-03-26](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/e25bcef3-888a-4f3e-b64b-223257e43fa2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 26, 2025
- [483 - US Specialty Formulations LLC - 2024-07-02](https://www.keypedia.com/records/483/us-specialty-formulations-llc/02180e72-25a9-4bdf-970c-9567cf7a7ce8) — source: FDA, date: July 2, 2024
- [FDA Inspection 1243882 - US Specialty Formulations LLC - 2024-07-02](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/dd9ee101-2a34-4453-ad4e-ba79c9bf11c3) — classification: Official Action Indicated (OAI), source: FDA, date: July 2, 2024
- [483 - US Specialty Formulations LLC - 2022-04-26](https://www.keypedia.com/records/483/us-specialty-formulations-llc/2ff0d13c-a3ce-40eb-ad34-b5b1e999f613) — source: FDA, date: April 26, 2022
- [FDA Inspection 1167934 - US Specialty Formulations LLC - 2022-04-26](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/737bef48-423a-4dcc-92af-ca91074c2095) — classification: Official Action Indicated (OAI), source: FDA, date: April 26, 2022
- [FDA Inspection 1167934 - US Specialty Formulations LLC - 2022-04-26](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/c2529d65-9b9a-4df4-95ab-aed2f8190c7d) — classification: Official Action Indicated (OAI), source: FDA, date: April 26, 2022
- [FDA Inspection 1097950 - US Specialty Formulations LLC - 2019-07-23](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/d3651a69-ca0b-4e10-a392-9496baabe17c) — classification: Official Action Indicated (OAI), source: FDA, date: July 23, 2019
- [FDA Inspection 1023411 - US Specialty Formulations LLC - 2017-08-29](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/33cfa969-db8c-466f-a448-732a50bd78d8) — classification: Official Action Indicated (OAI), source: FDA, date: August 29, 2017
- [FDA Inspection 928445 - US Specialty Formulations LLC - 2015-05-29](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/5d7280bc-635f-46cf-a2e4-4cc7a960a004) — classification: Official Action Indicated (OAI), source: FDA, date: May 29, 2015
- [FDA Inspection 871574 - US Specialty Formulations LLC - 2014-03-18](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/99f409a5-5f1d-436e-8b47-ab3de37814d4) — classification: No Action Indicated (NAI), source: FDA, date: March 18, 2014

## Related Companies

- [Marcus Research Laboratory, Inc.](https://www.keypedia.com/companies/marcus-research-laboratory-inc/6ed62b27-3200-4374-b004-ec4c541dc0d9)
- [Specialty Minerals, Inc.](https://www.keypedia.com/companies/specialty-minerals-inc/fa1116ce-bf42-40c1-b849-1d18b36fdd72)
- [Jost Chemical Co.](https://www.keypedia.com/companies/jost-chemical-co/42828577-321c-4fe1-a2b7-ec1df451cd8e)
- [SEL Biochem Xinjiang Co., Ltd](https://www.keypedia.com/companies/sel-biochem-xinjiang-co-ltd/b2468c97-6768-42f6-8382-65232a349e3e)
- [Corden Pharma Bergamo SPA](https://www.keypedia.com/companies/corden-pharma-bergamo-spa/8f926414-d5ef-49c4-be33-d7c81dfc55ea)
- [Central Glass Co., Ltd.](https://www.keypedia.com/companies/central-glass-co-ltd/df9e20f9-4cd5-4ab6-b166-4216c0d628db)
- [BASF AS avd Sandefjord](https://www.keypedia.com/companies/basf-as-avd-sandefjord/1b76cb86-c9db-45f9-bfdd-e2eaec2a67b7)
- [Henan Lihua Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/henan-lihua-pharmaceutical-co-ltd/0fcfa9cb-e461-4a79-b60a-20bd1198621a)
- [Harman Finochem Limited](https://www.keypedia.com/companies/harman-finochem-limited/7622941a-bad2-45c3-bd91-07d2bb63f905)
- [Kreative Organics Private Limited](https://www.keypedia.com/companies/kreative-organics-private-limited/a7ac8ac3-c335-4d67-ba2d-5cdc59181996)

## Related Officers

- [Vascular Neurologist Investigator](https://www.keypedia.com/people/sean-d-duke/ea627ffa-8e7c-4c2e-a9e0-31a41fe44ccf)
- [Investigator](https://www.keypedia.com/people/edmund-f-mrak/a43cf86a-c020-4948-bff6-358b2453908a)
- [Ucheabuchi C. Chudi-nwankwor](https://www.keypedia.com/people/ucheabuchi-c-chudi-nwankwor/18b01d08-3cfd-4ace-97b2-5f54b6427661)
- [Rabinah Anatullah](https://www.keypedia.com/people/rabinah-anatullah/ec3a3855-2e6c-460f-827c-16fe0f406635)
- [Investigator](https://www.keypedia.com/people/lu-chen/d0700911-c592-4da7-a445-5dfb2a4bedff)